By contrast, PRKAA2 is subject to more frequent mutations and, although many might be passenger mutations caused by genomic instability of cancer cells, some may cause a loss of function consistent with the idea that α2 is a tumour suppressor. Here, PRKAA2 is linked to neoplasm.